An injection designed to tackle obesity could reduce the risk of heart attacks and strokes – regardless of how much weight they lose while on the drug, according to a new study.
Researchers looked at the effects of semaglutide – which is a prescription drug that suppresses appetite and is sold under the brand names Wegovy, Ozempic and Rybelsus.
They said the anti-obesity jabs could also benefit the cardiovascular health of millions of adults, with one researcher likening it to when statins were introduced in the 1990s.
Subscribe here: http://bit.ly/1rbfUog
For more news, analysis and features visit: www.bbc.com/news
#Ozempic #WeightLoss #BBCNews
President Donald Trump has said the US will "obliterate" Iranian power plants if the Strait of Hormuz is not open…
PALERMO (ITALPRESS) – “UniCredit nel 2025 ha erogato in Sicilia nuovi finanziamenti per 1,6 miliardi di euro, di cui oltre…
ROMA (ITALPRESS) – Hanno aperto alle 7 e chiuderanno alle ore 23, per poi riaprire domani dalle 7 alle 15…